🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Laboratorios Lesvi, S.L. — Licensed Medicines

11 medicines held by Laboratorios Lesvi, S.L. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 11 products held by Laboratorios Lesvi, S.L.
MedicineActive substanceLicence holderStatus
BUCCOLAM 10 mg oromucosal solution
EU/1/11/709/004
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 2.5 mg oromucosal solution
EU/1/11/709/001
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 5 mg oromucosal solution
EU/1/11/709/002
Midazolam Laboratorios Lesvi, S.L.
BUCCOLAM 7.5 mg oromucosal solution
EU/1/11/709/003
Midazolam Laboratorios Lesvi, S.L.
Buprenorphine Neuraxpharm
EU/1/24/1809/001-003
Buprenorphine hydrochloride Laboratorios Lesvi, S.L.
Buprenorphine Neuraxpharm
EU/1/24/1809/004-006
Buprenorphine hydrochloride Laboratorios Lesvi, S.L.
Buprenorphine Neuraxpharm
EU/1/24/1809/007-009
Buprenorphine hydrochloride Laboratorios Lesvi, S.L.
Buprenorphine Neuraxpharm
EU/1/24/1809/010-012
Buprenorphine hydrochloride Laboratorios Lesvi, S.L.
Tuzulby 20 mg prolonged-release chewable tablets
EU/1/24/1907/001
Methylphenidate hydrochloride Laboratorios Lesvi, S.L.
Tuzulby 30 mg prolonged-release chewable tablets
EU/1/24/1907/002
Methylphenidate hydrochloride Laboratorios Lesvi, S.L.
Tuzulby 40 mg prolonged-release chewable tablets
EU/1/24/1907/003
Methylphenidate hydrochloride Laboratorios Lesvi, S.L.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.